FDA Approves Vortioxetine for Treating Depression in Adults
FDA approves vortioxetine for treating depression in adults
It will be marketed as Brintellix, by Takeda Pharmaceuticals and Lundbeck, and will be available in 5-mg, 10-mg, 15-mg, and 20-mg tablets. The Food and Drug Administration approved the drug Oct. 1. The prescribing information and the Takeda/Lundbeck … Read more on Clinical Psychiatry News Digital Network
More cuts 'will put mums at risk in Holles St'
Referring to the ongoing adversarial system of litigation, where patients seek compensation for alleged negligence, she said it was driving some clinical staff to illness, depression and early retirement. "We actually now have a medical disorder called … Read more on Irish Independent
Depression may precede Parkinson's
Dr David Straker, an adjunct assistant clinical professor of psychiatry at Columbia University Medical Centre, agreed that depression should be treated promptly and aggressively. But "we always want to rule out other neurologic diseases when a person … Read more on Health24.com
Clinical Depression by Psychiatrist Dr Michael Williamson.wmv – http://www.lawsonclinic.com.au – Dr Michael Williamson, Psychiatrist (Mood Disorder Unit, The Lawson Clinic) speaks about the different types of clinical dep…
Tags: edical c, mood disorder, food and drug administration, university medical centre, columbia university, treating depression